Nosocomial Pathogens and Antimicrobial Resistance: Modern Challenges and Future Opportunities

Ana R Freitas; Guido Werner

doi:10.3390/microorganisms11071685

Nosocomial Pathogens and Antimicrobial Resistance: Modern Challenges and Future Opportunities

Microorganisms. 2023 Jun 28;11(7):1685. doi: 10.3390/microorganisms11071685.

Authors

Ana R Freitas^{1

2

3}, Guido Werner⁴

Affiliations

¹ 1H-TOXRUN, One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, 4585-116 Gandra, Portugal.
² Laboratory of Microbiology, UCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
³ Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
⁴ Division of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, National Reference Centre for Staphylococci and Enterococci, Wernigerode Branch, 38855 Wernigerode, Germany.

Abstract

Antimicrobial resistance (AMR) has become a critical global health emergency in the 21st century, with the greatest burden in resource-limited settings [...].

Publication types

Editorial

Grants and funding

G.W. receives a grant from the Federal Ministry for Health to run the National Reference Centre for Staphylococci and Enterococci (current period 2023–2025). A.R.F. acknowledges the Junior Research Position (CEECIND/02268/2017) granted by the FCT—Fundação para a Ciência e a Tecnologia.